Stock listing

A1W50M Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: A1W50M · LSX · EUR · DE

A1W50M:LSX is the listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. The company is actively engaged in research and development to advance its innovative therapies in regenerative medicine. With a market capitalization of around €280.9 million, Fate Therapeutics continues to make strides in the biotech sector, reflecting its commitment to addressing critical health challenges. Recent news and filings highlight the company's ongoing projects and strategic initiatives in the field.

A1W50M:LSXEURDEUpdated July 24, 2026
Fate Therapeutics, Inc. logo
Ticker
A1W50M:LSX
Asset type
Stock
Market cap
$280.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Fate Therapeutics, Inc. A1W50M:LSX stock context

A1W50M:LSX is the listing for Fate Therapeutics, Inc., a biotechnology company dedicated to developing cellular immunotherapies for cancer and immune disorders. The company is actively engaged in research and development to advance its innovative therapies in regenerative medicine. With a market capitalization of around €280.9 million, Fate Therapeutics continues to make strides in the biotech sector, reflecting its commitment to addressing critical health challenges. Recent news and filings highlight the company's ongoing projects and strategic initiatives in the field.

Research Fate Therapeutics, Inc.

Alternate listings